Literature DB >> 7543439

Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.

T Hasegawa1, K Seki, P Yang, T Hirose, K Hizawa, T Wada, J Wakabayashi.   

Abstract

To assess the histological grade in benign and malignant cartilage tumors of bone by more objective methods, we examined the differentiation and proliferative activity of tumor cells in six enchondromas, five chondroblastomas, and 13 chondrosarcomas immunohistochemically. A variable number of cells in all tumors showed S-100 protein and vimentin immunoreactivity. In fully differentiated cartilage of enchondromas and low grade chondrosarcomas, tenascin, which is an extracellular matrix glycoprotein, was present in small amounts or absent but was increased at the periphery of tumor lobules and even in the matrix throughout the high grade chondrosarcomas. Higher rate and intensity of proliferating cell nuclear antigen (PCNA) reactivity were found in chondrosarcomas, especially in spindle-shaped cells of high grade tumors, than in enchondromas. The distribution of PCNA-positive cells almost corresponded to the regions with tenascin reactivity. One tumor of high grade chondrosarcoma showed p53 protein immunoreactivity. Aberrant expression of cytokeratin was observed in four chondroblastomas. The expression of desmin was identified in relatively large proportions of enchondromas and chondrosarcomas, regardless of their benign or malignant nature and histological grade. Smooth muscle or muscle-specific actins also were present in a smaller number of tumors. Based on these findings, it is concluded that unusual staining characteristics were present, in addition to those of a chondroblastic nature, in the cartilage tumors of bone. Tenascin and PCNA positivity of various degrees in all chondroblastomas may suggest that they are chondrogenic tumors having a relatively high proliferative activity, albeit their benign clinical course. Proliferative activity of tumor cells in enchondromas and chondrosarcomas correlated well with their histological grade. Tenascin may play a role in promoting tumor cell proliferation of cartilagenous neoplasms and, on the other hand, the alterations of extracellular matrix involving tenascin synthesis seem to be a result of tumor development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543439     DOI: 10.1016/0046-8177(95)90004-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

2.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

3.  Ki-67 immunostaining as a tool in the diagnosis of central cartilage lesions.

Authors:  L J Weinstein; E F McCarthy
Journal:  Iowa Orthop J       Date:  1996

4.  Enchondromas in children: imaging appearance with pathological correlation.

Authors:  Guillaume Bierry; Darcy A Kerr; G Petur Nielsen; Andrew E Rosenberg; Ambrose J Huang; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2012-02-27       Impact factor: 2.199

5.  Abl expression, tumour grade, and apoptosis in chondrosarcoma.

Authors:  M O'Donovan; J M Russell; J J O'Leary; J A Gillan; M P Lawler; E F Gaffney
Journal:  Mol Pathol       Date:  1999-12

6.  Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.

Authors:  T Aigner; S Dertinger; S I Vornehm; J Dudhia; K von der Mark; T Kirchner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  Peripheral ossifying fibroma and juxtacortical chondrosarcoma in cynomolgus monkeys (Macaca fascicularis).

Authors:  Barthel Schmelting; Martina Zöller; Joachim Kaspareit
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-01       Impact factor: 1.232

8.  The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours.

Authors:  Peter Fm Choong; Toshiyuki Kunisada; John Slavin; Stephen Schlicht; Rodney Hicks
Journal:  Int Semin Surg Oncol       Date:  2004-11-08

9.  Clinical and histopathological prognostic factors in chondrosarcomas.

Authors:  S Daugaard; O Myhre-Jensen; T Schiødt; A G Jurik; J Keller; H T Mouridsen; B Lund
Journal:  Sarcoma       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.